DIABETIC NEPHROPATHY - CAN IT BE PREVENTED - ARE THERE RENAL PROTECTIVE ANTIHYPERTENSIVE DRUGS OF CHOICE

被引：7

作者：

BAUER, JH ^{[1
]}

机构：

[1] HARRY S TRUMAN MEM VET HOSP, MED SERV, COLUMBIA, MO 65201 USA

来源：

SOUTHERN MEDICAL JOURNAL | 1994年 / 87卷 / 10期

关键词：

D O I：

10.1097/00007611-199410000-00017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic nephropathy is the most common cause of end-stage renal disease in the United States. This review focuses on (1) the problem of diabetic nephropathy, (2) hypertension in patients with diabetes mellitus, (3) the pathophysiology of diabetic nephropathy, and (4) therapeutic methods designed to provide renal protection to patients with diabetes mellitus. The treatments discussed are (1) strict metabolic control, (2) strict control of systemic hypertension, (3) control of glomerular hypertension, and (4) dietary protein restriction. Diabetic nephropathy can be retarded; renal protection depends primarily on strict metabolic control and strict control of systemic hypertension. With respect to the kidney, there are no unique renal protective antihypertensive drugs of choice.

引用

页码：1043 / 1053

页数：11

共 111 条

[1]

ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496

[2] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].

ANDERSON, S ;

RENNKE, HG ;

BRENNER, BM .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000

[3] RENAL HEMODYNAMIC-EFFECTS OF CALCIUM-ANTAGONISTS IN RATS WITH REDUCED RENAL MASS [J].

ANDERSON, S .

HYPERTENSION, 1991, 17 (03) :288-295

[4] RENAL EFFECTS OF NICARDIPINE, A CALCIUM-ANTAGONIST, IN HYPERTENSIVE TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY [J].

BABA, T ;

TOMIYAMA, T ;

MURABAYASHI, S ;

TAKEBE, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) :425-429

[5]

BABA T, 1989, DIABETOLOGIA, V32, P40

[6] EFFECTS OF DILTIAZEM OR LISINOPRIL ON MASSIVE PROTEINURIA ASSOCIATED WITH DIABETES-MELLITUS [J].

BAKRIS, GL .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) :707-708

[7] TREATMENT OF ARTERIAL-HYPERTENSION IN DIABETIC HUMANS - IMPORTANCE OF THERAPEUTIC SELECTION [J].

BAKRIS, GL ;

BARNHILL, BW ;

SADLER, R .

KIDNEY INTERNATIONAL, 1992, 41 (04) :912-919

[8]

BARSOTTI G, 1988, CLIN NEPHROL, V29, P280

[9] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF ENALAPRIL IN PATIENTS WITH CLINICAL DIABETIC NEPHROPATHY [J].

BAUER, JH ;

REAMS, GP ;

HEWETT, J ;

KLACHKO, D ;

MESSINA, C ;

KNAUS, V .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (05) :443-457

[10]

BAUER JH, 1990, J AM SOC NEPHROL, V1, pS80

← 1 2 3 4 5 6 7 8 9 10 →